Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients. [electronic resource]
- Biological psychiatry Jun 2013
- e35-6 p. digital
Publication Type: Case Reports; Letter
1873-2402
10.1016/j.biopsych.2012.07.022 doi
Adult Antidepressive Agents--therapeutic use Depression--blood Eukaryotic Initiation Factor-2--blood Glycogen Synthase Kinase 3--blood Glycogen Synthase Kinase 3 beta Humans Ketamine--therapeutic use Male Phosphorylation--drug effects Sirolimus--blood Time Factors Young Adult